Goodwin Biotechnology, Inc. Completes Major Expansion Project

PLANTATION, Fla.--(BUSINESS WIRE)--Goodwin Biotechnology, Inc. (GBI) announced last week the completion of construction of their expanded manufacturing suites. This expansion included the doubling of the cGMP manufacturing space and the addition of a 200L and 500L stirred tank bioreactor train to their hollow fiber and perfusion capabilities. On April 23rd the GBI team, together with representatives of GBI’s parent company, Wallace Pharmaceuticals and key invited guests celebrated the commissioning of their new facility with a ribbon cutting ceremony and champagne toast.